Cargando…
Current controversies in infective endocarditis
Infective endocarditis is a life-threatening disease caused by a focus of infection within the heart. For clinicians and scientists, it has been a moving target that has an evolving microbiology and a changing patient demographic. In the absence of an extensive evidence base to guide clinical practi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754014/ https://www.ncbi.nlm.nih.gov/pubmed/26918142 http://dx.doi.org/10.12688/f1000research.6949.1 |
_version_ | 1782415961094094848 |
---|---|
author | Cahill, Thomas J. Prendergast, Bernard D. |
author_facet | Cahill, Thomas J. Prendergast, Bernard D. |
author_sort | Cahill, Thomas J. |
collection | PubMed |
description | Infective endocarditis is a life-threatening disease caused by a focus of infection within the heart. For clinicians and scientists, it has been a moving target that has an evolving microbiology and a changing patient demographic. In the absence of an extensive evidence base to guide clinical practice, controversies abound. Here, we review three main areas of uncertainty: first, in prevention of infective endocarditis, including the role of antibiotic prophylaxis and strategies to reduce health care-associated bacteraemia; second, in diagnosis, specifically the use of multimodality imaging; third, we discuss the optimal timing of surgical intervention and the challenges posed by increasing rates of cardiac device infection. |
format | Online Article Text |
id | pubmed-4754014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | F1000Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-47540142016-02-24 Current controversies in infective endocarditis Cahill, Thomas J. Prendergast, Bernard D. F1000Res Review Infective endocarditis is a life-threatening disease caused by a focus of infection within the heart. For clinicians and scientists, it has been a moving target that has an evolving microbiology and a changing patient demographic. In the absence of an extensive evidence base to guide clinical practice, controversies abound. Here, we review three main areas of uncertainty: first, in prevention of infective endocarditis, including the role of antibiotic prophylaxis and strategies to reduce health care-associated bacteraemia; second, in diagnosis, specifically the use of multimodality imaging; third, we discuss the optimal timing of surgical intervention and the challenges posed by increasing rates of cardiac device infection. F1000Research 2015-11-18 /pmc/articles/PMC4754014/ /pubmed/26918142 http://dx.doi.org/10.12688/f1000research.6949.1 Text en Copyright: © 2015 Cahill TJ and Prendergast BD http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Cahill, Thomas J. Prendergast, Bernard D. Current controversies in infective endocarditis |
title | Current controversies in infective endocarditis |
title_full | Current controversies in infective endocarditis |
title_fullStr | Current controversies in infective endocarditis |
title_full_unstemmed | Current controversies in infective endocarditis |
title_short | Current controversies in infective endocarditis |
title_sort | current controversies in infective endocarditis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754014/ https://www.ncbi.nlm.nih.gov/pubmed/26918142 http://dx.doi.org/10.12688/f1000research.6949.1 |
work_keys_str_mv | AT cahillthomasj currentcontroversiesininfectiveendocarditis AT prendergastbernardd currentcontroversiesininfectiveendocarditis |